Viyash Scientific Limited (BOM:512529)
India · Delayed Price · Currency is INR 250.15
-6.70 (-2.61%)
At close: May 27, 2026
Viyash Scientific Market Cap
Viyash Scientific has a market cap or net worth of 112.11 billion as of May 27, 2026. Its market cap has increased by 188.97% in one year.
Market Cap
112.11B
Enterprise Value
116.34B
Revenue
34.20B
Ranking
n/a
PE Ratio
64.05
Stock Price
250.15
Market Cap Chart
Since January 5, 2005, Viyash Scientific's market cap has increased from 347.75M to 112.11B, an increase of 32,137.39%. That is a compound annual growth rate of 30.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 109.18B | 20.38% |
| Dec 31, 2025 | 90.70B | 106.22% |
| Dec 31, 2024 | 43.98B | 55.47% |
| Dec 29, 2023 | 28.29B | 29.89% |
| Dec 30, 2022 | 21.78B | -45.17% |
| Dec 31, 2021 | 39.72B | -4.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 352.64B |
| AstraZeneca Pharma India | 215.11B |
| Granules India | 186.24B |
| Jubilant Pharmova | 159.31B |
| Rubicon Research | 156.47B |
| Caplin Point Laboratories | 154.21B |
| CORONA Remedies | 103.03B |
| Procter & Gamble Health | 92.32B |